University of Arizona Cancer Center - Cancer Center Support Grant
University of Arizona Cancer Center - Cancer Center Support Grant
批准号:
10246540
负责人:
Joann B. Sweasy
金额:
$15.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-01 至 2022-06-30
关键词:
AccountabilityAmbulatory Care FacilitiesAreaArizonaArsenicAutomobile DrivingBasic ScienceBehavioralBioinformaticsCancer BiologyCancer CenterCancer Center Support GrantCancer ControlCancer PatientCancer SurvivorCatchment AreaCellular biologyChemopreventive AgentClinicClinical ResearchClinical TrialsCollaborationsCommunicationCommunitiesComprehensive Cancer CenterContinuance of lifeDevelopmentDiagnosisDietDisease ProgressionEconomically Deprived PopulationEducationElderlyEnvironmentEnvironmental Risk FactorEpidemiologyEpigenetic ProcessExcisionExposure toFundingGeneticGenetic RiskGeographyGoalsHealthHealth SciencesHispanic AmericansHispanicsIndividualInfrastructureInstitutionInterdisciplinary StudyInternationalInterventionInvestmentsLatinoLeadershipMalignant NeoplasmsMentorsMissionMovementNCI-Designated Cancer CenterNative AmericansOutreach ResearchPatient CarePeer ReviewPhilanthropic FundPositioning AttributePrecision Medicine InitiativePreclinical TestingPreventionPrevention ResearchProcessPublicationsQuality of lifeReportingResearchResearch PersonnelResource DevelopmentResource SharingResourcesScienceSignal TransductionSkin CancerStrategic PlanningTestingTherapeutic InterventionTimeToxic effectTrainingTraining ActivityTranslational ResearchUnderserved PopulationUniversitiesWorkauthoritybasecancer carecancer health disparitycancer imagingcancer preventioncarcinogenesiscare providersclinically relevantcollegecost effectivenessfallsfollow-upimprovedinnovationknowledge translationmembernext generationoutreach programprecision medicinepreventprogramsprotocol developmentracial and ethnicrecruitscreeningsocioeconomicssquare footsuccesssynergismtherapeutic development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary / Abstract: Overall
The University of Arizona Cancer Center (UACC) in Tucson, Arizona has been an NCI-designated Cancer
Center since 1978 and a Comprehensive Cancer Center since 1990. It was founded as a matrix center within
the University of Arizona (UA), and its members represent 43 Colleges and 11 Departments. In 2014, the
UACC was elevated to a status equivalent to that of a College, reporting directly to the Senior Vice President of
Health Sciences. At this time, Andrew S. Kraft, MD, was appointed Director of the UACC. With authority for all
cancer-related activities at the UA, he is spearheading the utilization of the significant Institutional support to
enhance the Program. This includes the recently completed $100M 220,000 square foot outpatient clinic in
Phoenix, which will greatly enhance translational research, an expansion of basic research space with
occupancy of 20,000 square feet within two years, and an Institutional Commitment of $232M dollars over the
next five years. The functionality of the Center has been enhanced by optimization of the Administration and
Senior Leadership infrastructure. The UACC Strategic Plan for 2015–2020 calls for the continuation of the
highly innovative and impactful team science based on four robust cornerstone Programs: Cancer Biology,
Cancer Imaging, Therapeutic Development, and Cancer Prevention and Control. Strategic recruitment and
pilot funding is focused on team building, including development of inter-programmatic collaborations and
movement of research into the clinic. The UACC will continue to invest in its eight integrated Shared
Resources that enhance the capabilities of UACC investigators in basic, prevention, translational, and clinical
research, and another in development. The Clinical Trials Office has been strengthened, and investments
supporting precision medicine initiatives are ongoing. The UACC is the only major academic Cancer Center in
a 400 square mile area of driving distance and is committed to serving the residents in this region and its direct
catchment area of southern Arizona. Thus, it has a focus on skin cancer and arsenic exposure as well as the
needs of Hispanics, Native Americans, the elderly, and the economically disadvantaged. It has established a
robust infrastructure of international, national, and regional collaborations and outreach programs together with
research spanning epidemiology, genetics, epigenetics, cell biology, and signaling mechanisms, as well as
targeted interventions and understudied survivorship issues. To capture the emerging synergies, the positions
of Associate Director of Cancer Disparities and Associate Director of Precision Medicine and Bioinformatics
have been created and filled by nationally recognized experts. The UACC emphasis on inclusive training of the
next generation of cancer researchers has had demonstrable success in graduation of Native American and
Latinos. The research generated by UACC members is characterized by its impact, its relevance to the
catchment area, and its innovation. The Strategic Plan builds on the work that has resulted in 1,756 cancer-
related publications in the reporting period and its current portfolio of $44M in peer-reviewed support.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aberrant DNA Repair and Lupus
-
批准号:10210397
-
项目类别:
-
资助金额:$75.43万
-
财政年份:2020
-
负责人:Joann B. Sweasy
-
依托单位:
Aberrant DNA Repair and Lupus
-
批准号:10381734
-
项目类别:
-
资助金额:$76.37万
-
财政年份:2020
-
负责人:Joann B. Sweasy
-
依托单位:
Aberrant DNA Repair and Lupus
-
批准号:10598566
-
项目类别:
-
资助金额:$76.81万
-
财政年份:2020
-
负责人:Joann B. Sweasy
-
依托单位:
DNA Polymerase Beta Variants and Cancer
-
批准号:10044775
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2019
-
负责人:Joann B. Sweasy
-
依托单位:
Assessing the role of the DNA repair landscape in immune checkpoint therapy
-
批准号:9317114
-
项目类别:
-
资助金额:$21.86万
-
财政年份:2017
-
负责人:Joann B. Sweasy
-
依托单位:
The Role of a PARP1 Genetic Variant in Development of Lupus
-
批准号:9251237
-
项目类别:
-
资助金额:$20.71万
-
财政年份:2016
-
负责人:Joann B. Sweasy
-
依托单位:
The Role of a PARP1 Genetic Variant in Development of Lupus
-
批准号:9092164
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2016
-
负责人:Joann B. Sweasy
-
依托单位:
Base Excision Repair and Autoimmunity
-
批准号:8226821
-
项目类别:
-
资助金额:$24.88万
-
财政年份:2012
-
负责人:Joann B. Sweasy
-
依托单位:
Base Excision Repair and Autoimmunity
-
批准号:8431731
-
项目类别:
-
资助金额:$20.79万
-
财政年份:2012
-
负责人:Joann B. Sweasy
-
依托单位:
DNA Polymerase Beta and Cell Transformation
-
批准号:8307756
-
项目类别:
-
资助金额:$34.34万
-
财政年份:2011
-
负责人:Joann B. Sweasy
-
依托单位:
DNA Polymerase Beta Variants and Cancer
-
批准号:8252218
-
项目类别:
-
资助金额:$36.82万
-
财政年份:2010
-
负责人:Joann B. Sweasy
-
依托单位:
DNA Polymerase Beta Variants and Cancer
-
批准号:8664386
-
项目类别:
-
资助金额:$36.45万
-
财政年份:2010
-
负责人:Joann B. Sweasy
-
依托单位:
DNA Polymerase Beta Variants and Cancer
-
批准号:8090366
-
项目类别:
-
资助金额:$36.82万
-
财政年份:2010
-
负责人:Joann B. Sweasy
-
依托单位:
DNA Polymerase Beta Variants and Cancer
-
批准号:7945113
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2010
-
负责人:Joann B. Sweasy
-
依托单位:
DNA Polymerase Beta Variants and Cancer
-
批准号:9029861
-
项目类别:
-
资助金额:$42.28万
-
财政年份:2010
-
负责人:Joann B. Sweasy
-
依托单位:
DNA Polymerase Beta Variants and Cancer
-
批准号:8460528
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2010
-
负责人:Joann B. Sweasy
-
依托单位:
2010 DNA Damage, Mutation, and Cancer
-
批准号:7904387
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2010
-
负责人:Joann B. Sweasy
-
依托单位:
DNA Polymerase Beta and Cell Transformation
-
批准号:7726052
-
项目类别:
-
资助金额:$34.93万
-
财政年份:2009
-
负责人:Joann B. Sweasy
-
依托单位:
DNA Polymerase Beta and Breast Cancer
-
批准号:7239612
-
项目类别:
-
资助金额:$19.8万
-
财政年份:2007
-
负责人:Joann B. Sweasy
-
依托单位:
DNA Polymerase Beta and Breast Cancer
-
批准号:7410111
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2007
-
负责人:Joann B. Sweasy
-
依托单位: